Status:
UNKNOWN
Plastic vs Biodegradable Pancreatic Stent in Post-ERCP Pancreatitis Prevention
Lead Sponsor:
Instituto Ecuatoriano de Enfermedades Digestivas
Conditions:
Biliary Tract Diseases
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Multiple risk factors have been linked with post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP); therefore, it is critical to follow strategies to reduce associated risk, morbidity,...
Detailed Description
Endoscopic retrograde cholangiopancreatography (ERCP) is a high-skilled endoscopic procedure, which is currently mainly used as a therapeutic mean for various pancreaticobiliary disorders. Its most co...
Eligibility Criteria
Inclusion
- Patient is scheduled for ERCP
- Patient is 18 years old or older
- Biliary tract disease presence
- Non-manipulated pancreatic papilla
- Written informed consent provided
Exclusion
- Patient not requiring pancreatic stenting during ERCP
- Failed pancreatic stent placement
- Patients at risk of fluid overload
- Patients with cholangitis, sepsis, acute/flared up chronic pancreatitis
- Recent previous biliary tract manipulation (i.e., pancreatoscopy, wirsungoscopy, etc.)
- Hemodynamic instability
- Uncontrolled coagulopathy, kidney/liver failure, or any comorbidity with a meaningful impact on cardiac risk assessment (NHYA III/IV)
- Pregnancy or nursing
- Refuse to participate in the study or to sign corresponding informed consent
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2023
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT05307861
Start Date
February 1 2022
End Date
January 30 2023
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carlos Robles-Medranda
Guayaquil, Guayas, Ecuador, 090505